Ptc Therapeutics, Inc. · NASDAQ:PTCT
BlackRock, Inc. reported a 8.00% stake in Ptc Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 17, 2025
BlackRock, Inc. reported a 8.00% stake in Ptc Therapeutics, Inc., 6,274,384 shares, as a passive investor on Mar 31, 2025. Filed Apr 17, 2025 (Schedule 13G/A).
- Stake
- 8.00%
- Shares
- 6,274,384
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 8.00% | 6,274,384 |
Source
Related
- Ptc Therapeutics, Inc.
- BlackRock, Inc.
- Ptc Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Dec 4, 2025
- Form 4 · Schmertzler Michael · Oct 16, 2026
- Form 4 · Boulding Mark Elliott · Oct 13, 2026
- Form 4 · Schmertzler Michael · Oct 9, 2026
- Form 4 · Boulding Mark Elliott · Oct 7, 2026
- Form 4 · Steele Glenn Jr Md Phd · Oct 2, 2026